PHA-543613 hydrochloride

Catalog No. :
ACQFTR876
CAS No. :
1586767-92-1
Molecular Formula :
C15H18ClN3O2
Molecular Weight :
307.78

IUPAC Name:(R)-N-(quinuclidin-3-yl)furo[2,3-c]pyridine-5-carboxamide hydrochloride

PHA-543613 hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePHA-543613 hydrochloride
IUPAC Name(R)-N-(quinuclidin-3-yl)furo[2,3-c]pyridine-5-carboxamide hydrochloride
MDL No.MFCD12828748
Molecular FormulaC15H18ClN3O2
Molecular Weight307.78
SMILESO=C(C1=CC2=C(OC=C2)C=N1)N[C@H]3CN4CCC3CC4.[H]Cl
InChI KeyYMTPSZUBRSEWNY-ZOWNYOTGSA-N
Synonym13XQH31A5R | Furo(2,3-C)pyridine-5-carboxamide, N-(3R)-1-azabicyclo(2.2.2)oct-3-yl-, hydrochloride (1:1) | N-[(3r)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide hydrochloride | N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]furo[2,3-c]pyridine-5-ca
CAS No.1586767-92-1
PubChem CID56972222

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACQFTR876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKNYD076 route compound structure diagram
    ACKNYD076123536-14-1 In Stock
  2. Plus
  3. ACYGEQ718 route compound structure diagram
    ACYGEQ718478148-62-8 In Stock
  4. Then
  5. ACQFTR876 route product structure diagram
    ACQFTR8761586767-92-1
Inquiry

2. ACQFTR876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKNYD076 route compound structure diagram
    ACKNYD076123536-14-1 In Stock
  4. Then
  5. ACQFTR876 route product structure diagram
    ACQFTR8761586767-92-1
Inquiry

Comments (0)